Medication-induced osteoporosis: screening and treatment strategies
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Medication-induced osteoporosis: screening and treatment strategies
Authors
Keywords
-
Journal
Therapeutic Advances in Musculoskeletal Disease
Volume 6, Issue 5, Pages 185-202
Publisher
SAGE Publications
Online
2014-08-13
DOI
10.1177/1759720x14546350
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NCCN Task Force Report: Bone Health in Cancer Care
- (2017) Julie R. Gralow et al. Journal of the National Comprehensive Cancer Network
- Association between use of antiepileptic drugs and fracture risk: A systematic review and meta-analysis
- (2014) Chunhong Shen et al. BONE
- Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS)
- (2014) C. Moura et al. OSTEOPOROSIS INTERNATIONAL
- Glucocorticoids and bone: local effects and systemic implications
- (2014) Holger Henneicke et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Prevention of bone loss and vertebral fractures in patients with chronic epilepsy-Antiepileptic drug and osteoporosis prevention trial
- (2013) Antonio A. Lazzari et al. EPILEPSIA
- A fracture prevention service reduces further fractures two years after incident minimal trauma fracture
- (2013) John Van der Kallen et al. International Journal of Rheumatic Diseases
- Predictors of Fracture While on Treatment With Oral Bisphosphonates: A Population-Based Cohort Study
- (2013) Daniel Prieto-Alhambra et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A population-based case–control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate
- (2013) Joongyub Lee et al. JOURNAL OF GASTROENTEROLOGY
- Glucocorticoids and the regulation of growth hormone secretion
- (2013) Gherardo Mazziotti et al. Nature Reviews Endocrinology
- Use of Depot Medroxyprogesterone Acetate Contraception and Incidence of Bone Fracture
- (2013) Lee L. Lanza et al. OBSTETRICS AND GYNECOLOGY
- Regulation of ITAM adaptor molecules and their receptors by inhibition of calcineurin-NFAT signalling during late stage osteoclast differentiation
- (2012) M.S.F. Zawawi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Glucocorticoid-Induced Osteoporosis and Osteonecrosis
- (2012) Robert S. Weinstein ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy
- (2012) Dae Lim Koo et al. EPILEPSY RESEARCH
- A Phase 3, Double-blind, Randomised, Parallel-group, Placebo-controlled Study of Oral Weekly Alendronate for the Prevention of Androgen Deprivation Bone Loss in Nonmetastatic Prostate Cancer: The Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) Study
- (2012) Laurence H. Klotz et al. EUROPEAN UROLOGY
- Use of selective serotonin reuptake inhibitors and risk of fracture: A systematic review and meta-analysis
- (2012) Chun-Sick Eom et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
- (2012) S. Lekamwasam et al. OSTEOPOROSIS INTERNATIONAL
- Relationship between use of antidepressants and risk of fractures: a meta-analysis
- (2012) V. Rabenda et al. OSTEOPOROSIS INTERNATIONAL
- Fracture Risk and Bone Mineral Density Reduction Associated with Proton Pump Inhibitors
- (2012) Yuen Ting Lau et al. PHARMACOTHERAPY
- Proton Pump Inhibitors and Risk of Fracture: A Systematic Review and Meta-Analysis of Observational Studies
- (2011) Saowanee Ngamruengphong et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Proton Pump Inhibitors and Risk of Fractures: A Meta-Analysis of 11 International Studies
- (2011) Elaine W. Yu et al. AMERICAN JOURNAL OF MEDICINE
- Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment
- (2011) P. Hadji et al. ANNALS OF ONCOLOGY
- Association of Antiepileptic Drugs With Nontraumatic Fractures
- (2011) Nathalie Jetté et al. ARCHIVES OF NEUROLOGY
- Long-term outcomes of children and adolescents who had cerebral palsy with secondary osteoporosis
- (2011) Toshiyuki Iwasaki et al. CURRENT MEDICAL RESEARCH AND OPINION
- Fractures and Fanconi Syndrome due to Prolonged Sodium Valproate Use
- (2011) N. Dhillon et al. NEUROPEDIATRICS
- Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case–control studies
- (2011) Q. Wu et al. OSTEOPOROSIS INTERNATIONAL
- Antiepileptics and bone health
- (2011) Christian Meier et al. Therapeutic Advances in Musculoskeletal Disease
- Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study
- (2010) H. Eidtmann et al. ANNALS OF ONCOLOGY
- Proton Pump Inhibitor Use, Hip Fracture, and Change in Bone Mineral Density in Postmenopausal Women
- (2010) Shelly L. Gray ARCHIVES OF INTERNAL MEDICINE
- Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer
- (2010) Pamela Taxel et al. BJU INTERNATIONAL
- Meta-analysis: Risk of fractures with acid-suppressing medication
- (2010) Chun Shing Kwok et al. BONE
- Proton Pump Inhibitors and Histamine-2 Receptor Antagonists Are Associated With Hip Fractures Among At-Risk Patients
- (2010) Douglas A. Corley et al. GASTROENTEROLOGY
- Cyclosporin A in the oophorectomized rat: Unexpected severe bone resorption
- (2010) Colin Movsowitz et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Use of Depot Medroxyprogesterone Acetate and Fracture Risk
- (2010) Christian Meier et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2010) Matthew R. Smith et al. JOURNAL OF UROLOGY
- ACOG Committee Opinion No. 415: Depot Medroxyprogesterone Acetate and Bone Effects
- (2010) OBSTETRICS AND GYNECOLOGY
- American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
- (2010) Jennifer M. Grossman et al. ARTHRITIS CARE & RESEARCH
- Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates
- (2009) R. K. Dore et al. ANNALS OF THE RHEUMATIC DISEASES
- Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis
- (2009) Jacques Planas et al. BJU INTERNATIONAL
- Vertebral fractures in males with type 2 diabetes treated with rosiglitazone
- (2009) Tatiana Mancini et al. BONE
- Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC
- (2009) Stephanie L. Hines et al. BREAST CANCER RESEARCH AND TREATMENT
- Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results
- (2009) Adam M. Brufsky et al. Clinical Breast Cancer
- Proton-Pump Inhibitor Use Is Not Associated With Osteoporosis or Accelerated Bone Mineral Density Loss
- (2009) Laura E. Targownik et al. GASTROENTEROLOGY
- Age Dependence of Early Symptomatic Vertebral Fracture with High-Dose Glucocorticoid Treatment for Collagen Vascular Diseases
- (2009) Ichiro Tatsuno et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. JOURNAL OF UROLOGY
- KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary
- (2009) Bertram L. Kasiske et al. KIDNEY INTERNATIONAL
- Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2009) David M Reid et al. LANCET
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
- (2009) Michael Gnant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates
- (2009) F. de Vries et al. OSTEOPOROSIS INTERNATIONAL
- Association between vitamin D receptor gene polymorphisms, falls, balance and muscle power: results from two independent studies (APOSS and OPUS)
- (2009) R. Barr et al. OSTEOPOROSIS INTERNATIONAL
- The Risk of Fractures Associated with Thiazolidinediones: A Self-controlled Case-Series Study
- (2009) Ian J. Douglas et al. PLOS MEDICINE
- Incidence and risk factors for low trauma fractures in men with prostate cancer
- (2008) Henrik G. Ahlborg et al. BONE
- Increase in Vertebral Fracture Risk in Postmenopausal Women Using Omeprazole
- (2008) Christian Roux et al. CALCIFIED TISSUE INTERNATIONAL
- Fracture Risk Associated with Different Types of Oral Corticosteroids and Effect of Termination of Corticosteroids on the Risk of Fractures
- (2008) Peter Vestergaard et al. CALCIFIED TISSUE INTERNATIONAL
- Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older Adults
- (2008) Elaine W. Yu et al. CALCIFIED TISSUE INTERNATIONAL
- Use of proton pump inhibitors and risk of osteoporosis-related fractures
- (2008) L. E. Targownik et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
- (2008) Y. K. Loke et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group
- (2008) David M. Reid et al. CANCER TREATMENT REVIEWS
- The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women
- (2008) Peter Vestergaard et al. CONTRACEPTION
- Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis
- (2008) Peyman Hadji CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)
- (2008) S. E. Kahn et al. DIABETES CARE
- Thiazolidinedione-induced skeletal fragility - mechanisms and implications
- (2008) Andrew Grey DIABETES OBESITY & METABOLISM
- Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study
- (2008) B CROMER et al. FERTILITY AND STERILITY
- Approach to the Prostate Cancer Patient with Bone Disease
- (2008) Susan L. Greenspan JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Risedronate Prevents Bone Loss in Breast Cancer Survivors: A 2-Year, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- (2008) Susan L. Greenspan et al. JOURNAL OF CLINICAL ONCOLOGY
- Single-Point Assessment of Warfarin Use and Risk of Osteoporosis in Elderly Men
- (2008) Claudine Woo et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Antiepileptic drug use and rates of hip bone loss in older men: A prospective study
- (2008) K. E. Ensrud et al. NEUROLOGY
- Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy
- (2008) A. M. Pack et al. NEUROLOGY
- Integrated Analysis of Zoledronic Acid for Prevention of Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole
- (2008) A. Brufsky et al. ONCOLOGIST
- Regulatory pathways revealing new approaches to the development of anabolic drugs for osteoporosis
- (2008) T. J. Martin et al. OSTEOPOROSIS INTERNATIONAL
- Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy
- (2008) Merete Alice Lyngstad‐Brechan et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- The effects of heparin and low molecular weight heparins on bone
- (2007) Raghav Rajgopal et al. THROMBOSIS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation